Non-Peptidic CRF1 Receptor Antagonists for the Treatment of Anxiety,Depression and Stress Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|1|5|467-493

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.5, 2002-10, pp. : 467-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Peptidic GnRH Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 11, Iss. 22, 2004-11 ,pp. : 3017-3028

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin-4 Receptor Antagonists for the Treatment of Depression and Anxiety Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1145-1151

Bentham Science Publishers

Access to resources Recommend Favorite

Melanin-Concentrating Hormone MCH1 Receptor Antagonists: A Potential New Approach to the Treatment of Depression and Anxiety Disorders

By Shimazaki Toshiharu   Yoshimizu Takao   Chaki Shigeyuki  

CNS Drugs, Vol. 20, Iss. 10, 2006-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Non-peptidic δ opioid receptor agonists and antagonists (2000 – 2012)

By Fujii Hideaki   Takahashi Toshihiro   Nagase Hiroshi  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1181-1208

Informa Healthcare

Access to resources Recommend Favorite